Fig. 3From: Efficacy and safety of rebamipide liquid for chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II studyTime to onset of grade ≥ 3 oral mucositis. The y-axis shows the percentage of patients who have not developed grade ≥ 3 mucositisBack to article page